|
Volumn 131, Issue 1, 2000, Pages 99-107
|
The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway
a a a a a a |
Author keywords
Leukaemic cells; Nuclear factor kappaB; p38 and ERK kinases; SB203580; Transcriptional activity
|
Indexed keywords
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
ENZYME INHIBITOR;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE KINASE;
OKADAIC ACID;
PHOSPHATASE;
RAF PROTEIN;
STRESS ACTIVATED PROTEIN KINASE;
SYNAPTOPHYSIN;
SYNAPTOTAGMIN;
ARTICLE;
CELL LINE;
CONTROLLED STUDY;
ENZYME ACTIVATION;
ENZYME DEFICIENCY;
ENZYME INHIBITION;
ERYTHROLEUKEMIA CELL;
GENE OVEREXPRESSION;
GENETIC TRANSCRIPTION;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
TRANSCRIPTION REGULATION;
|
EID: 0033812246
PISSN: 00071188
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bjp.0703534 Document Type: Article |
Times cited : (99)
|
References (38)
|